BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1823824)

  • 1. [131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma.
    Corbett R; Pinkerton R; Tait D; Meller S
    J Nucl Biol Med (1991); 1991; 35(4):228-31. PubMed ID: 1823824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients.
    Klingebiel T; Feine U; Treuner J; Reuland P; Handgretinger R; Niethammer D
    J Nucl Biol Med (1991); 1991; 35(4):216-9. PubMed ID: 1823821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
    Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
    J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
    Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
    Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B
    J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
    Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
    Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
    J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with palliative [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Gasparini M; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):241-3. PubMed ID: 1726677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.
    Troncone L; Rufini V; Riccardi R; Lasorella A; Mastrangelo R
    J Nucl Biol Med (1991); 1991; 35(4):232-6. PubMed ID: 1823825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators.
    Lumbroso J; Hartmann O; Schlumberger M
    J Nucl Biol Med (1991); 1991; 35(4):220-3. PubMed ID: 1823822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after.
    Hör G; Maul FD; Kornhuber B; Schwabe D; Hesse J; Manegold KH; Baüm RP; Gerein V
    J Nucl Biol Med (1991); 1991; 35(4):207-15. PubMed ID: 1823820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
    Matthay KK; Tan JC; Villablanca JG; Yanik GA; Veatch J; Franc B; Twomey E; Horn B; Reynolds CP; Groshen S; Seeger RC; Maris JM
    J Clin Oncol; 2006 Jan; 24(3):500-6. PubMed ID: 16421427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
    Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
    Stanková J; Kavan P; Krízová H; Hermanská E; Dosel P; Sázel M
    Cas Lek Cesk; 2001 Jan; 140(1):13-7. PubMed ID: 11242978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.
    Sari O; Uğur O; Emir S; Akyüz C
    Turk J Pediatr; 2001; 43(1):29-33. PubMed ID: 11297155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
    Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
    J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.